Healthcare Startups Highlight Direct-to-Consumer Diagnostics, Digital Twins, and Managing Pharmacy Costs at INVEST Digital Health Conference

[Sponsored] MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed a wide range of healthcare startups seeking to address painpoints in healthcare, from digital twin technology to support oncology drug development to alternative payment plans. The post Healthcare Startups Highlight Direct-to-Consumer Diagnostics, Digital Twins, and Managing Pharmacy Costs at INVEST Digital Health Conference appeared…

Read More

J&J’s $2.2B Ollin Buyout Brings Late-Stage Eye Drug; Blackstone Deal Adds Trial Funding

Johnson & Johnson’s Ollin Biosciences acquisition comes with a Phase 3-ready bispecific antibody. The companies say this eye drug offer advantages over Vabysmo, a Roche drug approved for wet age-related macular degeneration and diabetic macular edema. The post J&J’s $2.2B Ollin Buyout Brings Late-Stage Eye Drug; Blackstone Deal Adds Trial Funding appeared first on MedCity…

Read More